One of the biggest potential impacts is to the supply chain, says John Ransom, managing director of healthcare research. “We source a lot of [active pharmaceutical ingredients] from India and China.”
Recorded February 25, 2020
Markets & Investing April 01, 2024 Market rally driven by a broadening of the market and optimism that...
Markets & Investing April 01, 2024 Raymond James CIO Larry Adam reminds investors they need to be well...
Markets & Investing April 01, 2024 Doug Drabik discusses fixed income market conditions and offers...